News
MarketBeat on MSN12h
With Novo Nordisk's CEO Out, Wall Street Wants an American LeaderCompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...
Eli Lilly's (LLY) sees a 60% sales jump from April to May in India for its obesity/ diabetes drug Mounjaro. Read more here.
Best Life on MSN15h
Ozempic Users Face 2x Higher Risk of Permanent Vision Loss, Researchers WarnOzempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...
The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback